Literature DB >> 9343620

Alcohol abuse: a risk factor for surgical wound infections?

A Rantala1, O P Lehtonen, J Niinikoski.   

Abstract

BACKGROUND: The incidence of postoperative surgical site infections (SSIs) is difficult to estimate because of the current trend of early discharge after surgery. Both operation-related and host factors should be taken into consideration in the prevention of SSIs. We wanted to determine the actual incidence of SSIs and evaluate the risk factors in our clinic, using an extended follow-up period of 30 days after operations.
METHODS: We performed a prospective follow-up survey of SSIs over a 3.5-month period including a 1-month follow-up after discharge with written instructions and a telephone survey. The SSIs were defined according to Centers for Disease Control and Prevention criteria. Forty-three patient parameters were recorded, and risk factors for SSI were sought and tested by using multiple logistic regression analysis.
RESULTS: The follow-up was completed in 772 of 807 patients. The SSI rates in these patients were 5.3% in clean, 7.1% in clean-contaminated, 6.2% in contaminated, and 28.1% in dirty operations. Seventy-one percent of infections were not diagnosed until after discharge from the hospital. According to multiple logistic regression analysis, alcohol abuse (p < 0.0001), wound contamination class (p < 0.05), and operation duration of over 2 hours (p < 0.05) were independently significant risk factors for SSI.
CONCLUSIONS: A major portion of SSIs are found only after follow-up is extended during the postdischarge period. Alcohol abuse is a significant risk factor for SSI and should be taken into account when determining the susceptibility of an individual patient.

Entities:  

Mesh:

Year:  1997        PMID: 9343620     DOI: 10.1016/s0196-6553(97)90082-1

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  7 in total

Review 1.  [The alcoholic patient in the daily routine].

Authors:  Jan-Philipp Breuer; Tim Neumann; Andreas Heinz; Wolfgang J Kox; Claudia Spies
Journal:  Wien Klin Wochenschr       Date:  2003-09-30       Impact factor: 1.704

2.  Impact of alcohol use on 30-day complication and readmission rates after elective spinal fusion (≥2 levels) for adult spine deformity: a single institutional study of 1,010 patients.

Authors:  Aladine A Elsamadicy; Owoicho Adogwa; Victoria D Vuong; Amanda Sergesketter; Gireesh Reddy; Joseph Cheng; Carlos A Bagley; Isaac O Karikari
Journal:  J Spine Surg       Date:  2017-09

Review 3.  [Alcohol use disorder: risks in anesthesia and intensive care medicine].

Authors:  M Sander; T Neumann; V von Dossow; H Schönfeld; A Lau; V Eggers; C Spies
Journal:  Internist (Berl)       Date:  2006-04       Impact factor: 0.743

4.  N-Acetyl Cysteine Treatment Restores Early Phase Fracture Healing in Ethanol-Fed Rats.

Authors:  Michael J Duryee; Anand Dusad; Carlos D Hunter; Kusum K Kharbanda; Joseph D Bruenjes; Karen C Easterling; Justin C Siebler; Geoffrey M Thiele; Dennis A Chakkalakal
Journal:  Alcohol Clin Exp Res       Date:  2018-05-27       Impact factor: 3.455

5.  A matched-control analysis on the effects of alcohol use disorder following primary reverse shoulder arthroplasty.

Authors:  Electra Nassis; Alexander S Imas; Eric S Roth; Samuel J Swiggett; Asad M Ashraf; Keith B Diamond; Afshin E Razi; Jack Choueka
Journal:  J Orthop       Date:  2021-02-24

6.  Three-year mortality among alcoholic patients after intensive care: a population-based cohort study.

Authors:  Steffen Christensen; Martin B Johansen; Lars Pedersen; Reinhold Jensen; Kim M Larsen; Anders Larsson; Else Tønnesen; Christian F Christiansen; Henrik T Sørensen
Journal:  Crit Care       Date:  2012-01-08       Impact factor: 9.097

7.  An underlying diagnosis of osteonecrosis of bone is associated with worse outcomes than osteoarthritis after total hip arthroplasty.

Authors:  Jasvinder A Singh; Jason Chen; Maria C S Inacio; Robert S Namba; Elizabeth W Paxton
Journal:  BMC Musculoskelet Disord       Date:  2017-01-09       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.